Healthcare expenditures among community-dwelling adults with thyroid cancer in the United States: A propensity score matched analysis by Sandipan Bhattacharjee, Moteb Khobrani, Ziyad Alrabiah, Jawad Bilal, Irbaz Bin Riaz

Get full text

A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart... by Thomas Ward, Ruth D. Lewis, Tray Brown, Garth Baxter, Antonio Ramirez de Arellano

“…Methods A Markov cohort model was generated to assess the pharmacoeconomic impact of patiromer treatment in regulating HK in patients with advanced CKD with and without HF. …”
Get full text

Economic evaluation of the chronic hepatitis B treatment strategies in Italy by Sergio Iannazzo, Barbara Coco, Maurizia Brunetto, Francesca Rossetti, Antonietta Caputo, Maria De Francesco, Ferruccio Bonino

“…Recent studies gave way to early identification of non-responders to peg-interferon with a stopping rule based on virologic/serologic markers at week 12. A pharmacoeconomic simulation model was developed to support the economic evaluation of HBeAg-negative CHB treatment strategies, which either involve first line peg-interferon with stopping rule and switch to current most effective analogue entecavir or tenofovir, or nucleosides analogues in first line treatment. …”
Get full text

Drug therapies for treatment of idiopathic pulmonary fibrosis: a systematic review, Bayesian network meta-analysis, and cost-effectiveness analysisResearch in context by Chunyang Zhao, Yan Yin, Chengrui Zhu, Min Zhu, Tianlong Ji, Zhonghao Li, Jiayi Cai

“…Findings: 51 publications comprising 12,551 participants with IPF were analysed for the NMA, and the findings indicated that pirfenidone and N-acetylcysteine (NAC) + pirfenidone were the most efficacious and tolerable. The pharmacoeconomic analysis showed that NAC + pirfenidone was associated with the highest potentiality of being cost-effective at willingness-to-pay (WTP) thresholds of US$150,000 and $200,000, on the basis of quality-adjusted life years (QALYs), disability-adjusted life years (DALYs) and mortality, with the probability ranging from 53% to 92%. …”
Get full text

Efficacy and safety of polysaccharide iron complex capsules compared with iron sucrose in hemodialysis patients: study protocol for a randomized, open-label, positive control, mult... by Renhua Lu, Xu Zhang, Xudong Cai, Xiaoxia Wang, Hua Li, Li Wang, Yijun Zhou, Jianxiao Shen, Qian Liu, Haifen Zhang, Zhaohui Ni

“…Secondary endpoints include Hb, SF, hematocrit (Hct), HsCRP, pharmacoeconomic evaluation, drug costs, quality of life, and indicators of oxidative stress. …”
Get full text

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy by Mencacci C, Di Sciascio G, Katz P, Ripellino C

“…The study results are robust and in line with other pharmacoeconomic analyses comparing escitalopram with other SSRIs.Keywords: CEA, depression, escitalopram, Lombardy, ICER, SSRI…”
Get full text

Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective by Nimer S. Alkhatib, Abdulaali R. Almutairi, Omar S. Alkhezi, Osama M. Alfayez, Majed S. Al Yami, Omar A. Almohammed

Get full text

Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US by Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT

“…Glen T Schumock1, Robert D Gibbons2, Todd A Lee1,3,4,6, Min J Joo4, Robert J Valuck5, Leslie T Stayner61Center for Pharmacoeconomic Research, and Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA; 2Center for Health Statistics, and Departments of Medicine and Health Studies, Pritzker School of Medicine, University of Chicago, Chicago, IL, USA; 3Center for Management of Complex Chronic Care, Hines VA Hospital, Hines, IL, USA; 4Section of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA; 5Department of Clinical Pharmacy, School of Pharmacy, University of Colorado, Aurora, CO, USA; 6Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USABackground: The US Food and Drug Administration has issued warnings about a potential link between leukotriene receptor-modifying agents (LTMA) and suicide. …”
Get full text

Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study by Leys AM, Ramboer E, Favreau M, Denhaerynck K, MacDonald K, Abraham I, Brié H

“…Anita M Leys,1,2 Eva Ramboer,3 Mérédis Favreau,3 Kris Denhaerynck,4,5 Karen MacDonald,4 Ivo Abraham,4,6– 8 Heidi Brié3 1Department of Ophthalmology, Universitair Ziekenhuis Gasthuisberg, KULeuven, Leuven, Belgium; 2Oogartsen, Alken, Belgium; 3Novartis Pharma, Vilvoorde, Belgium; 4Matrix45, Tucson, AZ, USA; 5Department of Public Health, University of Basel, Basel, Switzerland; 6Center for Health Outcomes and Pharmacoeconomic Research, University of Arizona, Tucson, AZ, USA; 7Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA; 8Department of Family and Community Medicine, College of Medicine – Tucson, University of Arizona, Tucson, AZ, USACorrespondence: Heidi BriéN.V. …”
Get full text

ASSESSMENT OF CLINICO-ECONOMIC EFFICACY OF MEDICAL TREATMENT OF STABLE ISCHEMIC HEART DISEASE PATIENTS WHO UNDERWENT MYOCARDIAL REVASCULARIZATION by N. D. Sveshnikova, F. N. Paleev

“…Implementation of pharmacoeconomic analysis into the logistic technologies of medical organizations may promote the solution of this problem.Aim: To analyze real-practice data on medical therapy of patients with stable ischemic heart disease (IHD) during their hospital stay for transcutaneous coronary stent placement and coronary artery bypass grafting.Materials and methods: With the help of a structured form on medical treatment we extracted and analyzed data from 131 clinical records of patients with stable IHD who were hospitalized in 2014 to the Department of Internal Diseases and Department of Cardiovascular Surgery; 60 were patients after stent placement and 71, after coronary artery bypass grafting. …”
Get full text

Probabilistic modeling of the drug development domain: A Bayesian domain-knowledge application for pharmacovigilance by Schachter, Asher Daniel, 1967-

Get full text

Avaliação económica do erlotinib, docetaxel, pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulmão de não pequenas cÃ... by A. Araújo, B. Parente, R. Sotto-Mayor, E. Teixeira, T. Almodôvar, F. Barata, H. Queiroga, C. Pereira, H. Pereira, F. Negreiro, C. Silva

Get full text

Use of oral iron in managing iron deficiency anemia in children with intestinal failure by Badr Alsaleem, Nora Albanyan, Ahmad Alamer, Syed Mohammed Basheeruddin Asdaq, Yahya Mohzari, Mohannad M. Alrahili, Amna B. Albasheer, Ahmed A. Alrashed, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani

Get full text

Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis by Lorenzo Pradelli, Stanislaw Klek, Konstantin Mayer, Abdul Jabbar Omar Alsaleh, Martin D. Rosenthal, Axel R. Heller, Maurizio Muscaritoli

“…Methods We present a pharmacoeconomic simulation based on a systematic literature review with meta-analysis. …”
Get full text

Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race by Jifang Zhou, Jenilee Cueto, Naomi Y. Ko, Kent F. Hoskins, Nadia A. Nabulsi, Alemseged A. Asfaw, Colin C. Hubbard, Debanjali Mitra, Gregory S. Calip, Ernest H. Law

Get full text

Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan by Chan L, Chen CH, Hwang JJ, Yeh SJ, Shyu KG, Lin RT, Li YH, Liu LZ, Li JZ, Shau WY, Weng TC

“…Keywords: cost-effectiveness, pharmacoeconomic, Markov model, CCB, ARB…”
Get full text

PRIMUS – Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD... by Tkacz J, Evans KA, Touchette DR, Portillo E, Strange C, Staresinic A, Feigler N, Patel S, Pollack M

“…Joseph Tkacz,1 Kristin A Evans,1 Daniel R Touchette,2 Edward Portillo,3 Charlie Strange,4 Anthony Staresinic,5 Norbert Feigler,5 Sushma Patel,5 Michael Pollack5 1Life Sciences, IBM Watson Health, Cambridge, MA, USA; 2Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois College of Pharmacy, Chicago, IL, USA; 3Pharmacy Practice Division, University of Wisconsin-Madison School of Pharmacy, Madison, WI, USA; 4Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA; 5BioPharmaceuticals, US Medical Affairs, AstraZeneca, Wilmington, DE, USACorrespondence: Michael Pollack, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA, Tel +1 302 377 4911, Email michael.pollack1@astrazeneca.comPurpose: Patients with chronic obstructive pulmonary disease (COPD) may experience moderate (requiring outpatient care) or severe (requiring hospitalization) disease exacerbations. …”
Get full text

Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS by Luca Cindolo, Francesco Berardinelli, Caterina Fanizza, Marilena Romero, Luisella Pirozzi, Fabiola Raffaella Tamburro, Fabrizio Pellegrini, Fabio Neri, Andrea Pitrelli, Luigi Schips

“…For new-onset PCa, the IR was 8.01 (95% CI, 7.07-9.08) and 9.38 (95% CI, 8.32-10.58) per 1000 person-years The pharmacoeconomical evaluation showed that the net budget impact of the use of dutasteride vs. finasteride in 1000 BPH-treated patient for 1 year induces a saving of 3933 €. …”
Get full text

Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges by Przemysław Kardas, Martina Bago, Pilar Barnestein-Fonseca, Kristina Garuolienė, Anne Gerd Granas, Anne Gerd Granas, João Gregório, Maja Ortner Hadžiabdić, Barbora Kostalova, Francisca Leiva-Fernández, Pawel Lewek, Katerina Mala-Ladova, Marie Paule Schneider, Marie Paule Schneider, Job F. M. van Boven, Daisy Volmer, Ioli Ziampara, Tamás Ágh, Tamás Ágh

Get full text

Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants by Charles E. Leonard, Colleen M. Brensinger, Warren B. Bilker, Samantha E. Soprano, Neil Dhopeshwarkar, Todd E. H. Hecht, Scott E. Kasner, Edith A. Nutescu, Anne Holbrook, Matthew Carr, Darren M. Ashcroft, Cheng Chen, Sean Hennessy

Get full text